Ranibizumab in the treatment of patients with visual impairment due to diabetic macular edema

References

• Early Treatment Diabetic Retinopathy Study GroupPhotocoagulation for diabetic macular edema: ETDRS report no. 4Int Ophthalmol Clin1987272652723692708
   PubMedGoogle Scholar
• Early Treatment Diabetic Retinopathy Study GroupPhotocoagulation for DME: Early treatment diabetic retinopathy study report number 1Arch Ophthalmol1985103179618062866759
   PubMed Web of Science ®Google Scholar
• BandelloFParodiMBLanzettaPDiabetic macular edemaDev Ophthalmol2010477311020703045
   PubMedGoogle Scholar
• ETDRS Research GroupTreatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report Number 2. Early Treatment Diabetic Retinopathy Study Research GroupOphthalmology1987947617743658348
   PubMed Web of Science ®Google Scholar
• NeufeldGCohenTGengrinovitchSPoltorakZVascular endothelial growth factor (VEGF) and its receptorsFASEB J1999139229872925
   PubMed Web of Science ®Google Scholar
• GrantMBAfzalASpoerriPPanHShawLCMamesRNThe role of growth factors in the pathogenesis of diabetic retinopathyExpert Opin Investig Drugs20041312751293
   PubMed Web of Science ®Google Scholar
• PlateKHBreierGWeichHARisauWVascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivoNature19923598458481279432
   PubMed Web of Science ®Google Scholar
• ShweikiDItinASofferDKeshetEVascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesisNature19923598438451279431
   PubMed Web of Science ®Google Scholar
• AielloLPAveryRLArriggPGVascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disordersN Engl J Med1994331148014877526212
   PubMed Web of Science ®Google Scholar
• GardnerTWAntonettiDABarberAJLaNoueKFLevisonSWDiabetic retinopathy: More than meets the eyeSurv Ophthalmol200247Suppl 2S253S26212507627
   PubMed Web of Science ®Google Scholar
• ChunDWHeierJSToppingTMDukerJSBankertJMA pilot study of multiple intravitreal injections of ranibizumab in patients with center-involving clinically significant diabetic macular edemaOphthalmology20061131706171217011952
   PubMed Web of Science ®Google Scholar
• NguyenQDTatlipinarSShahSMVascular endothelial growth factor is a critical stimulus for diabetic macular edemaAm J Ophthalmol200614296196917046701
   PubMed Web of Science ®Google Scholar
• NguyenQDShahSMHeierJSREAD-2 Study GroupPrimary end point (six months) results of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) StudyOphthalmology200911621752181e119700194
   PubMed Web of Science ®Google Scholar
• NguyenQDShahSMKhwajaAAREAD-2 Study GroupTwo-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) studyOphthalmology20101172146215120855114
   PubMed Web of Science ®Google Scholar
• GenentechTwo pivotal Phase III Lucentis studies showed patients with diabetic macular edema experienced significant improvements in vision and fewer developed more advanced retinopathy Available from: http://www.gene.comAccessed June 28, 2011
   Google Scholar
• WolfSMassinPBandelloFRESOLVE Study GroupSafety and efficacy of ranibizumab treatment in patients with diabetic macular edema: 12-month results of the RESOLVE StudyPresented at the Association for Research in Vision and Ophthalmology meetingMay 3–7, 2009Fort Lauderdale, FL
   Google Scholar
• MassinPBandelloFGarwegJGSafety and efficacy of ranibizumab in diabetic macular edema (RESOLVE study): A 12-month, randomized, controlled, double-masked, multicenter phase II studyDiabetes Care2010332399240520980427
   PubMed Web of Science ®Google Scholar
• MitchellPBandelloFSchmidt-ErfurthUThe RESTORE study: Ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edemaOphthalmology201111861562521459215
   PubMed Web of Science ®Google Scholar
• MassinPAudrenFHaouchineBIntravitreal triamcinolone acetonide for diabetic diffuse macular edema: Preliminary results of a prospective controlled trialOphthalmology200411121822415019365
   PubMed Web of Science ®Google Scholar
• GilliesMCSutterFKSimpsonJMLarssonJAliHZhuMIntravitreal triamcinolone for refractory diabetic macular edema: Two-year results of a double-masked, placebo-controlled, randomized clinical trialOphthalmology20061131533153816828501
   PubMed Web of Science ®Google Scholar
• ElmanMJAielloLPBeckRWDiabetic Retinopathy Clinical Research Network. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edemaOphthalmology20101171064107720427088
   PubMed Web of Science ®Google Scholar
• ElmanMJBresslerNMQinHExpanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Diabetic Retinopathy Clinical Research NetworkOphthalmology201111860961421459214
   PubMed Web of Science ®Google Scholar
• OzturkBTKerimogluHBozkurtBOkudanSComparison of intravitreal bevacizumab and ranibizumab treatment for diabetic macular edemaJ Ocul Pharmacol Ther20112737337721631366
   PubMed Web of Science ®Google Scholar
• RosenfeldPJBrownDMHeierJSMARINA Study GroupRanibizumab for neovascular age-related macular degenerationN Engl J Med20063551419143117021318
   PubMed Web of Science ®Google Scholar
• BrownDMKaiserPKMichelsMRanibizumab versus verteporfin for neovascular age-related macular degenerationN Engl J Med20063551432144417021319
   PubMed Web of Science ®Google Scholar
• BrownDMMichelsMKaiserPKHeierJSSyJPIanchulevTRanibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR studyOphthalmology2009116576519118696
   PubMed Web of Science ®Google Scholar
• AbrahamPYueHWilsonLRandomized, double-masked, sham- controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER study year 2Am J Ophthalmol201015031532420598667
   PubMed Web of Science ®Google Scholar